Can a simple Nurse-Led program help older heart patients live healthier after stent surgery?
NCT ID NCT07683143
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests a nurse-led program designed to help elderly patients (age 60+) adopt healthier behaviors after undergoing a heart stent procedure (PCI). The program provides information, motivation, and practical skills through in-person sessions, phone calls, and hands-on training. Researchers will compare the program to standard care to see if it improves health-promoting behaviors, self-confidence, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nurse-led behavioral intervention
- What this could lead to
- If effective, this program could become a standard approach to help elderly heart patients adopt healthier lifestyles after stent surgery.
- What could go wrong
- This is a small, early-stage study with 78 participants, so results may not apply broadly. The intervention relies on patient motivation and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
78 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: 1. a confirmed diagnosis of coronary heart disease with a stable condition following PCI 2. age ≥60 years 3. normal cognitive and communication abilities 4. provision of written informed consent and voluntary participation in the study Exclusion criteria: 1. severe concomitant diseases affecting vital organs (e.g., liver, brain, or kidneys) 2. current participation in other similar studies
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary heart disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huaihe Hospital of Henan University
Kaifeng, Henan, 475000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shot of nicorandil before stenting might keep blood flowing
- Can a common gout pill shield hearts after stents?
- Can a simple blood test flag hidden heart risks after stenting?
- A 7,000-Person trial asks: is lifelong aspirin necessary for older hearts?
- Community health workers take on heart disease prevention in cleveland
- Can a heart injection grow new blood vessels?